🇺🇸 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE in United States

FDA authorised EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE on 7 July 2022

Marketing authorisations

FDA — authorised 7 July 2022

  • Application: ANDA212198
  • Marketing authorisation holder: ZYDUS PHARMS
  • Local brand name: EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA212362
  • Marketing authorisation holder: MSN LABS PVT LTD
  • Local brand name: EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA212373
  • Marketing authorisation holder: MACLEODS PHARMS LTD
  • Local brand name: EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA213654
  • Marketing authorisation holder: LUPIN LTD
  • Local brand name: EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA220511
  • Marketing authorisation holder: AJANTA PHARMA LTD
  • Local brand name: EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
  • Indication: TABLET, EXTENDED RELEASE
  • Status: approved

Read official source →

FDA

  • Application: ANDA212243
  • Marketing authorisation holder: CIPLA LTD
  • Local brand name: EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

FDA

  • Application: ANDA218483
  • Marketing authorisation holder: PRINSTON PHARMA INC
  • Local brand name: EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE approved in United States?

Yes. FDA authorised it on 7 July 2022; FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE in United States?

ZYDUS PHARMS holds the US marketing authorisation.